Irinotecan Generics - Manufacturers & Suppliers
Camptosar® (US & EU)
| Product/Composition:- | Irinotecan |
|---|---|
| Strength:- | 100 mg/5 mL, 300 mg/15 mL |
| Form:- | Injection/Infusion Solution |
| Reference Brands:- | Camptosar® (US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Irinotecan is a chemotherapy drug used to treat cancers like colorectal, ovarian, and lung cancer. Available as an intravenous solution in 100 mg/5 mL and 300 mg/15 mL strengths, it is marketed as Camptosar® by Pfizer, with generic versions like Irinotecan Accord and Irinotecan Mylan. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply, GMP compliance, and competitive pricing for oncology centers.
Irinotecan is an essential chemotherapy drug used in the treatment of various cancers, including colorectal, ovarian, and lung cancer. As a topoisomerase I inhibitor, it blocks DNA replication in cancer cells, preventing tumor growth. Available in intravenous (IV) solution forms, it is commonly provided in 100 mg/5 mL and 300 mg/15 mL strengths. Marketed under the brand Camptosar® by Pfizer, as well as in generic versions such as Irinotecan Accord and Irinotecan Mylan, it is widely sourced by B2B pharmaceutical wholesalers across the US and EU, ensuring reliable supply, GMP compliance, and competitive pricing for oncology centers.